Sector
PharmaceuticalsOpen
₹23.1Prev. Close
₹23.1Turnover(Lac.)
₹3.68Day's High
₹23.5Day's Low
₹2352 Week's High
₹5452 Week's Low
₹22.1Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
40.64P/E
16.55EPS
1.39Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 |
---|---|---|
Equity Capital | 17.67 | 12.37 |
Preference Capital | 0 | 0 |
Reserves | 10.44 | 1.03 |
Net Worth | 28.11 | 13.4 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 |
---|---|---|
Gross Sales | 122.34 | 58.48 |
Excise Duty | 0 | 0 |
Net Sales | 122.34 | 58.48 |
Other Operating Income | 0 | 0 |
Other Income | 0.1 | 0.14 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,713.65 | 129.24 | 4,07,155.15 | 1,181.05 | 0.8 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,666 | 71.05 | 1,47,295.24 | 594 | 0.54 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,452.35 | 25.07 | 1,16,664.33 | 1,438.15 | 0.9 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,207.1 | 59.03 | 1,07,673.27 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,421.9 | 52.42 | 1,01,358.17 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
No Record Found
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Mono Pharmacare Ltd
Summary
Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of M/s. Mono Chemist through Partnership Deed dated May 06, 1994. The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad. The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners. Further, Promoters acquired 100% ownership of the partnership firm on July 25, 2019.Accordingly, the Company acquired proprietorship firm of the Promoter, Panilam Lakhatariya M/s DLS Export pursuant to Deed of Business Transfer Agreement dated December 15, 2022 and on October 23, 2020 it acquired 99% ownership of Partnership Firms, M/s. Ahmedabad Medical Corporation (AMC) and M/s. Supal Distributors LLP from the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya dated January 10, 2023.In August 2023, Company laun
Read More
The Mono Pharmacare Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹23 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mono Pharmacare Ltd is ₹40.64 Cr. as of 01 Apr ‘25
The PE and PB ratios of Mono Pharmacare Ltd is 16.55 and 1.45 as of 01 Apr ‘25
The 52-week high/low is the highest and lowest price at which a Mono Pharmacare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Mono Pharmacare Ltd is ₹22.1 and ₹54 as of 01 Apr ‘25
Mono Pharmacare Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at -49.62%, 6 Month at -36.81%, 3 Month at -30.30% and 1 Month at -1.29%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.